Bioeconomy A ‘milestone for biotech industry in Portugal’: Lymphact acquired by UK company Tim Hinchliffe Jun 8, 2018 GammaDelta Therapeutics, which develops immunotherapies for cancer and other diseases, acquires Portugal's biotech startup Lymphact to advance its Gamma delta T cell platform. ... continue reading
Oct 23, 2023 “ESG has gone from a marketing gimmick to now being an essential component of corporate strategy” – Eelco van der Enden at Horasis Global Meeting
